These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 38400174)

  • 1. Vaccine Strategies to Elicit Mucosal Immunity.
    Song Y; Mehl F; Zeichner SL
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization: a review of strategies and challenges.
    Patel H; Yewale C; Rathi MN; Misra A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines, adjuvants and key factors for mucosal immune response.
    Correa VA; Portilho AI; De Gaspari E
    Immunology; 2022 Oct; 167(2):124-138. PubMed ID: 35751397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.
    Pilapitiya D; Wheatley AK; Tan HX
    EBioMedicine; 2023 Jun; 92():104585. PubMed ID: 37146404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccine design and delivery.
    Woodrow KA; Bennett KM; Lo DD
    Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.
    Dubois V; Locht C
    Front Immunol; 2021; 12():701285. PubMed ID: 34211481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
    Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
    mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in mucosal vaccines for the control of infectious diseases.
    Azegami T; Yuki Y; Kiyono H
    Int Immunol; 2014 Sep; 26(9):517-28. PubMed ID: 24914172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies.
    Hameed SA; Paul S; Dellosa GKY; Jaraquemada D; Bello MB
    NPJ Vaccines; 2022 Jun; 7(1):71. PubMed ID: 35764661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of Vaccination.
    Zepp F
    Methods Mol Biol; 2016; 1403():57-84. PubMed ID: 27076125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucosal immunity through systemic immunization: Phantom or reality?
    Su F; Patel GB; Hu S; Chen W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccination: onward and upward.
    Tsai CJY; Loh JMS; Fujihashi K; Kiyono H
    Expert Rev Vaccines; 2023; 22(1):885-899. PubMed ID: 37817433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical
    Gestal MC; Howard LK; Dewan KK; Harvill ET
    mSphere; 2022 Feb; 7(1):e0089221. PubMed ID: 35196124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal vaccines: Strategies and challenges.
    Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
    Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for mucosal vaccine development.
    Boyaka PN; Marinaro M; Vancott JL; Takahashi I; Fujihashi K; Yamamoto M; van Ginkel FW; Jackson RJ; Kiyono H; McGhee JR
    Am J Trop Med Hyg; 1999 Apr; 60(4 Suppl):35-45. PubMed ID: 10344675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.